These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11246296)

  • 1. Affective symptomatology in schizophrenia: a risk factor for tardive dyskinesia?
    Schulze TG; Müller DJ; Krauss H; Marwinski K; Maroldt AO; Novo Y Fernández A; Fimmers R; Held T; Maier W; Nöthen MM; Rietschel M
    Eur Psychiatry; 2001 Feb; 16(1):71-4. PubMed ID: 11246296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dyskinesia in schizophrenic patients: correlation with negative symptoms.
    Bartzokis G; Hill MA; Altshuler L; Cummings JL; Wirshing W; May PR
    Psychiatry Res; 1989 May; 28(2):145-51. PubMed ID: 2568650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulnerability to tardive dyskinesia.
    Wolf ME; DeWolfe AS; Ryan JJ; Lips O; Mosnaim AD
    J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizoaffective disorder: a form of schizophrenia or affective disorder?
    Evans JD; Heaton RK; Paulsen JS; McAdams LA; Heaton SC; Jeste DV
    J Clin Psychiatry; 1999 Dec; 60(12):874-82. PubMed ID: 10665641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affective disorders and tardive dyskinesia.
    Casey DE
    Encephale; 1988 Sep; 14 Spec No():221-6. PubMed ID: 2905650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tardive dyskinesia and positive and negative symptoms of schizophrenia. A study using instrumental measures.
    Yuen O; Caligiuri MP; Williams R; Dickson RA
    Br J Psychiatry; 1996 Jun; 168(6):702-8. PubMed ID: 8773812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comment on "tardive dyskinesia circa 2006".
    Rosenheck RA
    Am J Psychiatry; 2007 Jan; 164(1):170; author reply 170. PubMed ID: 17202564
    [No Abstract]   [Full Text] [Related]  

  • 8. Smoking and tardive dyskinesia in male patients with chronic schizophrenia.
    Zhang XY; Yu YQ; Sun S; Zhang X; Li W; Xiu MH; Chen DC; Yang FD; Zhu F; Kosten TA; Kosten TR
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1765-9. PubMed ID: 21723906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine efficacy in tardive dyskinesia in schizophrenic patients.
    Bassitt DP; Louzã Neto MR
    Eur Arch Psychiatry Clin Neurosci; 1998; 248(4):209-11. PubMed ID: 9810484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis.
    Apud JA; Egan MF; Wyatt RJ
    Schizophr Res; 2003 Sep; 63(1-2):151-60. PubMed ID: 12892869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication.
    Glazer WM; Morgenstern H; Schooler N; Berkman CS; Moore DC
    Br J Psychiatry; 1990 Oct; 157():585-92. PubMed ID: 1983390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders.
    de Jesus Mari J; Lima MS; Costa AN; Alexandrino N; Rodrigues-Filho S; de Oliveira IR; Tollefson GD
    Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):356-61. PubMed ID: 15538607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors related to the severity of tardive dyskinesia.
    Wade JB; Hart RP; Dougherty LM
    Brain Cogn; 1993 Sep; 23(1):71-80. PubMed ID: 8105823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased tardive dyskinesia in alcohol-abusing schizophrenic patients.
    Dixon L; Weiden PJ; Haas G; Sweeney J; Frances AJ
    Compr Psychiatry; 1992; 33(2):121-2. PubMed ID: 1347498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.
    Li CR; Chung YC; Park TW; Yang JC; Kim KW; Lee KH; Hwang IK
    World J Biol Psychiatry; 2009; 10(4 Pt 3):919-24. PubMed ID: 19995222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative symptoms as a risk factor for tardive dyskinesia in schizophrenia.
    Liddle PF; Barnes TR; Speller J; Kibel D
    Br J Psychiatry; 1993 Dec; 163():776-80. PubMed ID: 7905774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of negative symptoms with tardive dyskinesia in schizophrenic patients.
    Chiu H; Lau J; Lam L; Shum P
    Aust N Z J Psychiatry; 1993 Jun; 27(2):228-32. PubMed ID: 8103320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Schizophrenic deficit syndrome and neurologic tolerance].
    Verdoux H; Bourgeois M
    Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.